IBIkmal Hisyam Bakrin

Ikmal Hisyam Bakrin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ikmal Hisyam Bakrin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Review of Current Cell Annotation Systems for Histopathology Images

    by Ling Teoh Chai, Jian Tan Xiao, Khairul Shakir Ab Rahman, Ikmal Hisyam Bakrin, Meng Goh Kam, Wan Zuki Azman Wan Muhamad, Chin Lim Chee, Loon Cheor Wai, Thakerng Wongsirichot

    Histopathology techniques offer a unique way to study the structural and functional characteristics of biological model systems such as cultured cells, tissues and organoids. As the field of histopathology advances and more complex properties of living organisms are revealed through novel assays, there is a growing need for image analysis methods that are robust and easy to use. In many histopathology image analysis workflows, the first step is to segment cell nuclei, as they serve as the fundamental block for identifying individual cells in histopathology images. Such methods are crucial in a range of research studies, from counting cells and tracking moving populations to localizing proteins, classifying phenotypes and profiling treatments. Here, this review intended to provide an updated cell annotation system for histopathology images using the predetermined search strings and a set of inclusion criteria. Accordingly, 11 cell annotation systems (i.e., Image J, ASAP, Ilastik, Quanti.us, JS Segment Annotator, Labelme annotation tool, Labelbox, LabelImgTool, OpenSurfaces Segmentation UI, Cell Profiler and MATLAB Image Segmenter) was included. An in-depth discussion on the background of each included system was provided in this review alongside a brief comparison across different cell annotation systems.

  • Open Access

    A Quantitative Measurement Method for Nuclear-Pleomorphism Scoring in Breast Cancer

    by Chai Ling Teoh, Xiao Jian Tan, Khairul Shakir Ab Rahman, Ikmal Hisyam Bakrin, Kam Meng Goh, Joseph Jiun Wen Siet, Wan Zuki Azman Wan Muhamad

    Background/Objectives: Nuclear pleomorphism, a crucial determinant of breast cancer grading under the Nottingham Histopathology Grading (NHG) system, remains inadequately quantified in the existing literature. Motivated by this gap, our study seeks to investigate and establish correlations among morphological features across various scores of nuclear pleomorphism, as per the NHG system. We aim to quantify nuclear pleomorphism across these scores and validate our proposed measurement method against ground-truth data. Methods: Initially, we deconstruct the descriptions of nuclear pleomorphism into three core elements: size, shape, and appearance. These elements are subsequently mathematically modeled into equations, termed ESize, EShape, and EAppearance. These equations are then integrated into a unified model termed Harmonic Mean (HM). The HM equation yields a value approaching 1 for nuclei demonstrating characteristics of score-3 nuclear pleomorphism and near 0 for those exhibiting features of score-1 nuclear pleomorphism. Results: The proposed HM model demonstrates promising performance metrics, including Accuracy, Recall, Specificity, Precision, and F1-score, with values of 0.97, 0.96, 0.97, 0.94, and 0.95, respectively. Conclusions: In summary, this study proposes the HM equation as a novel feature for the precise quantification of nuclear pleomorphism in breast cancer.


    • 1 August 2023
      • Vol. 45  (2) , 149-155

    Genetic alterations in prostate cancer as diagnostic and prognostic markers

    by Hamidreza Saeidi, Patimah Ismail, Chandramathi Samudi Raju, Mohd Ghani Khairul-Asri, Ikmal Hisyam Bakrin

    Prostate cancer is the second-most frequently diagnosed cancer in men worldwide. Serum prostate-specific antigen is currently used for the early detection of prostate cancer. However, new biomarkers are needed to decrease over diagnosis and over treatment of prostate cancer due to limitations of prostate-specific antigen. Recently, molecular biomarkers have shown promising results for diagnosis and prognosis of prostate cancer. Molecular biomarkers have improved the sensitivity and specificity of prostate-specific antigen and studies are ongoing to identify molecular biomarkers as a replacement for prostate-specific antigen. This review aims to give an overview of emerging molecular biomarkers for diagnosis and prognosis of prostate cancer.


  • Open Access

    Artificial Intelligence (AI) in Breast Imaging: A Scientometric Umbrella Review

    by Xiao Jian Tan, Wai Loon Cheor, Li Li Lim, Khairul Shakir Ab Rahman, Ikmal Hisyam Bakrin

    Artificial intelligence (AI), a rousing advancement disrupting a wide spectrum of applications with remarkable betterment, has continued to gain momentum over the past decades. Within breast imaging, AI, especially machine learning and deep learning, honed with unlimited cross-data/case referencing, has found great utility encompassing four facets: screening and detection, diagnosis, disease monitoring, and data management as a whole. Over the years, breast cancer has been the apex of the cancer cumulative risk ranking for women across the six continents, existing in variegated forms and offering a complicated context in medical decisions. Realizing the ever-increasing demand for quality healthcare, contemporary AI has been envisioned to make great strides in clinical data management and perception, with the capability to detect indeterminate significance, predict prognostication, and correlate available data into a meaningful clinical endpoint. Here, the authors captured the review works over the past decades, focusing on AI in breast imaging, and systematized the included works into one usable document, which is termed an umbrella review. The present study aims to provide a panoramic view of how AI is poised to enhance breast imaging procedures. Evidence-based scientometric analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guideline, resulting in 71 included review works. This study aims to synthesize, collate, and correlate the included review works, thereby identifying the patterns, trends, quality, and types of the included works, captured by the structured search strategy. The present study is intended to serve as a “one-stop center” synthesis and provide a holistic bird’s eye view to readers, ranging from newcomers to existing researchers and relevant stakeholders, on the topic of interest.


  • Open Access

    Homologous recombination repair gene mutations in Malaysian prostate cancer patients

    by Hamidreza Saeidi, Chandramathi Samudi Raju, Patimah Ismail, Sayyidi Hamzi Abdul Raub, Noorjehan Omar, Ikmal Hisyam Bakrin

    Genetic alterations in the homologous recombination repair (HRR) genes are associated with an increased risk of prostate cancer development, and patients harboring these mutations can benefit from targeted therapy. The main aim of this study is to identify genetic alterations in HRR genes as a potential target for targeted treatment. In this study, targeted next generation sequencing (NGS) is used to analyze mutations in the protein-coding regions of the 27 genes involved in HRR and mutations in hotspots of 5 cancer-associated genes in four FFPE samples and three blood samples from prostate cancer patients. We identified two mutations in TP53 and KRAS. We also identified four conflicting interpretations of pathogenicity variants in BRCA2, STK11 genes and one variant of uncertain significance in the RAD51B gene. In addition, we detected one drug response variant in TP53, and two novel variants in CDK12 and ATM. Our results revealed some actionable pathogenic and potential pathogenic variants that may be associated with response to the Poly (ADP-ribose) polymerase (PARP) inhibitor treatment. More studies in a larger cohort are needed to evaluate and determine the association of HRR mutations with prostate cancer.


    • 1 April 2020
      • Vol. 42  (1) , 111-114

    Endocrine mucin-producing sweat gland carcinoma - newly described skin appendageal tumours

    by Ikmal Hisyam Bakrin, Sandhya Rajaintharan, Zahrah Tawil, Hasni Mahayidin

    Introduction: Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is a recently described adnexal tumour with a predilection for the face particularly the eye-lids. Considered to be a precursor lesion of mucinous adenocarcinoma, it may represent part of a morphological spectrum. We described a case of this entity, which we believe is the first case to be reported in Malaysia. Case report: A 59-year-old Chinese male presented with a slow-growing cystic lesion over the left lower lateral canthal region. The lesion became progressively larger and nodular within the last 6 months. Histologically, the lesion is a well-circumscribed intradermal tumour with pushing borders extending into the subcutaneous tissue. The tumour cells were arranged in lobules of solid, papillary and cribriform architecture. The cells displayed uniform, medium-sized, round to oval nuclei with stippled chromatin pattern and ample eosinophilic granular cytoplasm. Intracellular mucin (as highlighted by mucicarmine stain) was observed in areas with focal extracellular mucin seen. Mitotic figures were not particularly impressive. By immunohistochemistry study, the tumour cells expressed ER, PR, CK7, GCDFP-15, mammaglobin and EMA diffusely. Chromogranin A and synaptophysin highlighted a significant number of tumour cells. Discussion: The morphology and immunohistochemical profile similarities between EMPSGC and solid papillary carcinoma of the breast (SPCOTB) makes the former considered as the cutaneous analogue of the latter. In fact, one should rule out the possibility of metastatic SPCOTB before considering the diagnosis of EMPSGC.


    • 1 August 2016
      • Vol. 38  (2) , 117-22

    Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.

    by I H Bakrin, F A Hussain, Sharifah Emilia Tuan Sharif

    Synovial sarcoma (SS) is a malignant soft tissue tumour of uncertain histogenesis which is defined by the translocation t(X;18) that produces the fusion oncogenes SYT-SSX. The emergence of transducer-like enhancer of split 1 (TLE1) as a new immunohistochemical (IHC) marker for SS has offered an alternative to pathologists in differentiating SS from other histological mimics, especially in the setting of limited molecular facilities. We investigated the utility of IHC TLE1 expression against histomorphological features and other IHC markers in SS and non-SS tumours. Twenty-six cases of histologically diagnosed SS and 7 non-SS (for which SS was in the differential diagnosis) were subjected to TLE1 IHC staining, which was graded from 0 to 3+. Of the 26 SS cases, 12 each were biphasic and monophasic types and 2 were poorly-differentiated. TLE1 was expressed in 22/26 (84.6%) SS cases, of which 11/12 (91.7%) were biphasic, 10/12 (83.3%) monophasic and 1/2 (50%) poorly-differentiated tumours. Two of 7 (28.6%) non-SS cases were positive for TLE1. Immunopositivity of SS and non-SS cases for EMA were 20/26 (76.9%) and 2/7 (28.6%) respectively and for CK7 were 7/26 (26.9%) and 0/7 (0%) respectively. All cases were negative for CD34. Consistent histomorphological features for SS included mild nuclear pleomorphism, alternating tumour cellularity, fascicular growth pattern and thick ropy stromal collagen. In conclusion, TLE1 is not a stand-alone diagnostic IHC marker for SS. However, in the absence of molecular studies, it can contribute added diagnostic value in combination with morphological evaluation and other IHC markers such as EMA and CD34.